XIAOMI-W
01810
TENCENT
00700
JD HEALTH
06618
MEITUAN-W
03690
BILIBILI-W
09626
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Net interest income | 11.88%2.54B | 9.86%4.82B | 12.31%2.27B | 11.12%4.38B | 2.90%2.02B | 6.72%3.94B | 5.75%1.96B | -9.28%3.7B | -9.02%1.86B | -2.17%4.07B |
-Interest income | 17.37%6.21B | 64.91%11.49B | 96.04%5.29B | 34.71%6.96B | 3.64%2.7B | -16.75%5.17B | -24.19%2.6B | -16.89%6.21B | -7.01%3.43B | 11.33%7.47B |
-Interest expense | -21.50%-3.67B | -158.38%-6.67B | -346.03%-3.02B | -110.57%-2.58B | -5.90%-676.67M | 51.25%-1.23B | 59.46%-638.95M | 26.01%-2.51B | 4.52%-1.58B | -33.39%-3.4B |
Net service income | 59.76%603.39M | -61.46%866.8M | -21.58%377.67M | 87.83%2.25B | -24.93%481.6M | 1.32%1.2B | 10.95%641.51M | 3.04%1.18B | 0.27%578.21M | -1.23%1.15B |
-Service income | 50.14%712.47M | -55.65%1.08B | -15.86%474.54M | 72.93%2.43B | -23.32%564M | 1.81%1.41B | 8.59%735.54M | -3.60%1.38B | -6.76%677.35M | -3.01%1.43B |
-Service charge | -12.61%-109.08M | -15.53%-212.17M | -17.56%-96.87M | 12.30%-183.65M | 12.36%-82.4M | -4.71%-209.4M | 5.15%-94.03M | 30.19%-199.98M | 33.84%-99.13M | 9.52%-286.45M |
Net transaction income | 1,751.60%119.45M | 15.39%164.84M | -93.10%6.45M | --142.85M | --93.46M | ---- | ---- | ---- | ---- | ---- |
Securities and investments income | ---- | ---- | ---- | ---- | ---- | -42.34%179M | -42.83%84.28M | 213.92%310.44M | 1,641.92%147.42M | -70.25%98.89M |
Special items of operating revenue | -34.02%25.23M | 34.61%69M | 22.37%38.24M | -19.27%51.26M | -2.06%31.25M | 4.48%63.5M | -11.12%31.9M | -11.25%60.77M | 2.25%35.9M | -5.09%68.47M |
Operating revenue | 22.12%3.29B | -13.33%5.92B | 2.47%2.69B | 26.78%6.83B | -3.47%2.63B | 2.58%5.38B | 3.93%2.72B | -2.59%5.25B | -1.61%2.62B | -5.97%5.39B |
Operating expenses - before deducting impairment | -4.01%-1.59B | -5.07%-3.17B | -10.27%-1.53B | 0.17%-3.02B | 4.18%-1.39B | -6.65%-3.02B | -4.26%-1.45B | 0.62%-2.83B | -1.49%-1.39B | -5.56%-2.85B |
Operating profit before deducting impairment | 46.09%1.69B | -27.90%2.75B | -6.31%1.16B | 61.25%3.81B | -2.66%1.24B | -2.19%2.36B | 3.56%1.27B | -4.79%2.42B | -4.90%1.23B | -16.24%2.54B |
Impairment and provisions | -43.93%-559.72M | 48.38%-1.28B | 12.42%-388.89M | -126.14%-2.49B | -20.65%-444.06M | 13.86%-1.1B | 34.88%-368.05M | -98.36%-1.28B | -250.27%-565.19M | 25.74%-643.39M |
-Impairment of loans and advances | -246.74%-544.01M | 8.94%-731.31M | 48.57%-156.89M | -115.11%-803.1M | -160.62%-305.06M | 42.29%-373.34M | 67.95%-117.05M | -81.54%-646.97M | -299.73%-365.19M | -52.67%-356.39M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---98.24M | ---- | ---- |
-Impairment losses of other assets | 93.23%-15.72M | 67.20%-552M | -66.91%-232M | -131.82%-1.68B | 44.62%-139M | -36.72%-726M | -25.50%-251M | -85.02%-531M | -185.71%-200M | 54.66%-287M |
Operating profit after deducting impairment | 47.19%1.13B | 10.55%1.46B | -2.88%769.19M | 4.79%1.32B | -12.17%792M | 10.88%1.26B | 36.43%901.78M | -39.83%1.14B | -41.40%660.97M | -12.44%1.89B |
Special items of operating profit | 90.68%-122K | 6.14%-38.26M | -207.28%-1.31M | -1,368.37%-40.76M | 93.82%-426K | 96.82%-2.78M | -140.50%-6.9M | -150.18%-87.27M | -12.65%-2.87M | -162.79%-34.88M |
Operating profit | 47.42%1.13B | 11.08%1.43B | -2.99%767.88M | 1.79%1.28B | -11.54%791.58M | 19.81%1.26B | 35.98%894.89M | -43.40%1.05B | -41.53%658.11M | -16.20%1.86B |
Net profit from sale of subsidiaries | 83.33%-1K | 0.00%-10K | ---6K | 99.97%-10K | ---- | ---31.2M | ---31.2M | ---- | ---- | ---- |
Net profit from sale of fixed assets | 90.68%-122K | 215.38%2.83M | -207.28%-1.31M | 66.93%-2.45M | 93.82%-426K | -144.86%-7.41M | -140.50%-6.9M | 54.08%-3.03M | -12.65%-2.87M | -241.20%-6.59M |
Revaluation surplus | ---- | -7.25%-41.09M | ---- | -926.38%-38.31M | ---- | 105.50%4.64M | ---- | -197.78%-84.24M | ---- | -149.21%-28.29M |
Share of profits of associates | 0.06%430.48M | 4.91%688.96M | -5.18%430.24M | -5.91%656.69M | 4.78%453.75M | -1.75%697.95M | 5.17%433.05M | 1.21%710.37M | 0.22%411.76M | 6.39%701.86M |
Share of profit from joint venture company | 26.20%17.4M | -9.59%27.01M | 8.23%13.78M | -9.62%29.88M | -24.35%12.74M | -0.39%33.06M | 23.97%16.84M | 3.49%33.19M | 8.65%13.58M | 17.76%32.07M |
Special items of earning before tax | -90.68%122K | -6.20%38.26M | 190.89%1.31M | 424.98%40.79M | -95.82%450K | -92.29%7.77M | -25.52%10.77M | 188.74%100.72M | 468.21%14.46M | 164.75%34.88M |
Earning before tax | 30.37%1.58B | 8.71%2.14B | -3.67%1.21B | 0.22%1.97B | -4.51%1.26B | 8.64%1.97B | 20.31%1.32B | -30.23%1.81B | -29.30%1.1B | -10.81%2.59B |
Tax | -83.89%-183.85M | 22.12%-281.27M | 37.02%-99.98M | -17.22%-361.18M | 23.33%-158.75M | 2.62%-308.12M | -38.87%-207.04M | 10.39%-316.4M | 23.25%-149.09M | 17.44%-353.08M |
After-tax profit from continuing operations | 25.55%1.4B | 15.63%1.86B | 1.14%1.11B | -2.94%1.61B | -1.00%1.1B | 11.02%1.66B | 17.39%1.11B | -33.35%1.49B | -30.17%945.95M | -9.66%2.24B |
Earning After tax | 25.55%1.4B | 15.63%1.86B | 1.14%1.11B | -2.94%1.61B | -1.00%1.1B | 11.02%1.66B | 17.39%1.11B | -33.35%1.49B | -30.17%945.95M | -9.66%2.24B |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -214.85%-116K | -105.56%-37K | 406.06%101K |
Profits attributable to shareholders | 25.55%1.4B | 15.63%1.86B | 1.14%1.11B | -2.94%1.61B | -1.00%1.1B | 11.01%1.66B | 17.38%1.11B | -33.34%1.49B | -30.16%945.99M | -9.67%2.24B |
Dividend | 145.45%379.55M | 68.97%688.82M | 10.00%154.63M | 20.83%407.67M | 0.00%140.58M | 9.09%337.38M | 25.00%140.58M | -37.14%309.27M | -38.46%112.46M | 0.00%492.01M |
Basic earnings per share | 25.32%0.99 | 15.79%1.32 | 1.28%0.79 | -3.39%1.14 | -1.27%0.78 | 11.32%1.18 | 17.91%0.79 | -33.33%1.06 | -30.21%0.67 | -10.17%1.59 |
Diluted earnings per share | 24.00%0.93 | 14.95%1.23 | -3.85%0.75 | -9.32%1.07 | -1.27%0.78 | 11.32%1.18 | 17.91%0.79 | -33.33%1.06 | -30.21%0.67 | -10.17%1.59 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.